Study finds anti-smoking drug improves smokers’ chances of stopping
- Posted: March 28, 2013
Smokers have a higher probability of quitting smoking and a better overall cessation experience when taking varenicline (Chantix) compared to bupropion (marketed under various trade names as antidepressants and smoking cessation aids) and to placebo – unmedicated assisted smoking cessation – according to a University of Texas MD Anderson study published in the journal JAMA Psychiatry.
Among the research institutions NCI funds across the United States, it currently designates 67 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.